Ishita Pharmaceuticals Acquires 390 Shares of Ishita Drugs & Industries Ltd: Disclosure under SEBI Regulations

Ishita Pharmaceuticals, a related party of Ishita Drugs and Industries Limited, has acquired 390 shares of Rs. 10/- each of Ishita Drugs & Industries Ltd. This disclosure was made under regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The acquisition was made through the open market on February 26, 2026. The total share capital/voting capital and diluted share/voting capital were taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement.